Protective effect of turmeric extract on ethotrexate-induced intestinal damage and oxidative stress

Adel Rezaei Moghadam1, Daryoush Mohajeri2, Ali Namvaran-Abbas-Abad3

  • 1Young Researchers Club, Ardabil Branch, Islamic Azad University, Ardabil, Iran; Faculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran.

Abstract

Insights

Turmeric extract may protect the small intestine from methotrexate damage by reducing oxidative stress. This study found that turmeric significantly improved antioxidant levels and reduced intestinal damage in rats treated with methotrexate.

Area of Science:

  • Pharmacology and Toxicology
  • Gastroenterology
  • Natural Product Research

Background:

  • Methotrexate (MTX) is a widely used chemotherapy agent with mucositis as a significant side effect.
  • Oxidative stress plays a crucial role in MTX-induced intestinal damage.

Purpose of the Study:

  • To investigate the protective effects of turmeric extract against MTX-induced intestinal injury in a rat model.
  • To evaluate the impact of turmeric on oxidative stress markers in MTX-treated rats.

Main Methods:

  • Male Wistar albino rats were divided into six groups, receiving varying doses of turmeric extract and/or MTX.
  • Biochemical analyses included total antioxidant status (TAS), glutathione peroxidase (GPx), superoxidase dismutase (SOD), catalase (CAT), and malondialdehyde (MDA).
  • Histopathological examination of jejunum tissues assessed MTX-induced intestinal damage.

Main Results:

  • MTX treatment led to severe intestinal damage, including villus shortening, inflammation, and necrosis.
  • MTX significantly decreased SOD, GPx, and CAT levels, while increasing lipid peroxidation.
  • Turmeric extract administration, especially in combination with MTX, significantly increased antioxidant enzyme levels and reduced lipid peroxidation.

Conclusions:

  • Turmeric extract demonstrates significant protective effects on the small intestine against MTX-induced damage.
  • The antioxidant properties of turmeric are likely responsible for its protective mechanism.
  • Turmeric extract shows potential as a therapeutic agent to mitigate MTX-induced gastrointestinal toxicity.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
94
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
423